Gastric cancer remains the third leading cause of cancer-related mortality and the fifth most
common cancer worldwide. 1 There is marked global variation of disease with areas of high …

Gastric cancer is the third leading cause of cancer-related mortality and the fifth most
common cancer globally. An estimated 1 million new cases and 750,000 related deaths are …

Gastric cancer remains the third leading cause of cancer-related mortality and the fifth most
common cancer worldwide, responsible for an estimated 1 million new cases and more than …

Background Gastric intestinal metaplasia (GIM) is the premalignant stage of gastric cancer;
however, consensus on its management has not been established. Aim To determine the …

Intestinal metaplasia (IM) of the gastric mucosa is a relatively frequent precancerous lesion
(1). The inclusion of IM in a gastric biopsy pathology report often creates uncertainty for the …

Background & Aims Gastric intestinal metaplasia (GIM) is a common finding from routine
endoscopies. Although GIM is an early step in gastric carcinogenesis, there is controversy …

Gastric intestinal metaplasia is a precancerous change of the mucosa of the stomach with
intestinal epithelium, and is associated with an increased risk of dysplasia and cancer. The …

Simple Summary Gastric adenocarcinoma is the fifth most common cancer worldwide and
the fourth most lethal. It is often asymptomatic at an early stage, when survival rates are …

Gastric intestinal metaplasia (GIM) is a known premalignant condition of the human stomach
along the pathway to gastric cancer (GC). Histologically, GIM represents the replacement of …

Methods: We conducted a hospital-based study that included all patients with gastric IM
between 1992 and 2010, and the development of gastric adenocarcinoma was evaluated …